Trochanter Fixation Nail Advanced (TFNA) Weight Bearing

NCT ID: NCT03160508

Last Updated: 2021-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-20

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study documents real life weight bearing in patients treated with a TFNA, who are allowed for immediate weight bearing as tolerated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective data will be collected from 30 patients presenting a per- or inter-trochanteric fracture of the femur treated with the TFNA. Post-operatively patients will be asked to wear a sensor insole in their shoes for up to 3 months after surgical treatment. The sensor insole will be used in both feet and will not have any impact in patient's activities of daily living while allowing real time measurements of weight bearing.

In addition to weight bearing measurements, perceived pain (numeric rating scale), mobility (Parker Mobility Score and Time Up and Go Test) will be assessed at 6 and 12 weeks after surgical treatment and in conjunction with the standard (routine) of care follow up schedule. In order to investigate the relationship between these variables and the weight bearing measurements, patients or their care takers or assisting family members will be asked to document the daily use of the insole in a diary.

Finally, over the course of the study, anticipated adverse events (AE) that may affect the healing process will be collected. Special attention will be given to implant- or bone-related AEs. Images from patients with implant- or bone related AEs will be collected as per standard of care

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femur Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fracture fixation with the TFNA

Fracture fixation with the TFNA

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years and older
* Patients treated with the TFNA; i.e. according to the technique guide and the indications for use, patients who presented any of the following conditions:

* Stable or unstable pertrochanteric fractures
* Intertrochanteric fractures
* Basal neck fractures
* Combinations of pertrochanteric, intertrochanteric, and basal neck fractures
* Patients who were able to walk before the fracture and are prescribed full weight bearing as tolerated post-surgery
* Ability to understand the content of the patient information / informed consent form
* Willingness and ability to participate in the study according to the clinical investigation plan
* Signed and dated ethical committee approved written informed consent according to the local regulations

Exclusion Criteria

* Patients who are not allowed to full weight bearing as tolerated post-surgery
* Any condition, which impairs weight bearing (e.g. additional acute fracture on the ipsilateral and/or contralateral side, pain)
* Patients, who due to their condition, are in opinion of the Prinicipal Investigator (PI) unable to complete a reliable assessment
* Pregnancy or women planning to conceive within the study period
* Participation in any other medical device or medicinal product registry within the previous month that could, in opinion of the PI, influence the results of the present study
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Innovation Translation Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Blauth, Prof.

Role: PRINCIPAL_INVESTIGATOR

Medical University Innsbruck

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University Innsbruck

Innsbruck, , Austria

Site Status

Kantonsspital Baselland

Binningen, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TFNA weight bearing

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.